Mirae Asset Global ETFs Holdings’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-18,355
Closed -$23.7K – 3261
2026
Q1
$23.7K Buy
18,355
+402
+2% +$664 ﹤0.01% 3027
2025
Q4
$39.7K Sell
17,953
-373
-2% -$701 ﹤0.01% 2981
2025
Q3
$29.7K Sell
18,326
-3,289
-15% -$6.88K ﹤0.01% 3021
2025
Q2
$56K Sell
21,615
-1,014
-4% -$4K ﹤0.01% 2856
2025
Q1
$152K Buy
22,629
+967
+4% +$6.85K ﹤0.01% 2451
2024
Q4
$147K Buy
21,662
+912
+4% +$6K ﹤0.01% 2543
2024
Q3
$172K Buy
20,750
+1,226
+6% +$8.87K ﹤0.01% 2437
2024
Q2
$124K Buy
+19,524
New +$150K ﹤0.01% 2482

Other funds holding LUNG

Mirae Asset Global ETFs Holdings's LUNG Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 18,355 shares — an estimated $23.7K sold.

Mirae Asset Global ETFs Holdings first reported a position in LUNG in Q2 2024 and held it in 8 quarters. The position peaked at $172K in Q3 2024. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 18,355 Pulmonx shares in Q2 2026, an estimated $23.7K.
  • Mirae Asset Global ETFs Holdings first reported a position in Pulmonx in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Pulmonx position peaked at $172K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.